Bill > HR5228

This bill, the Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now (SCREEN) Act, aims to strengthen the authorities of the Food and Drug Administration (FDA) to address counterfeit drugs, illegal and synthetic opioids, and opioid-like substances. The key provisions of the bill include: increasing the maximum dollar amount of drugs subject to destruction upon being refused admission into the United States; providing the FDA with the authority to issue orders to cease distribution and recall adulterated or misbranded drugs; allowing the FDA to treat all drugs being offered for import from a manufacturer, distributor, or importer as adulterated or misbranded based on a pattern of such violations; establishing a fund to support the FDA's efforts to address the opioid and substance use epidemic, including through educational campaigns, enhanced surveillance, and increased staffing; and requiring the consideration of the potential for misuse and abuse when approving drugs that contain controlled substances.

Business and Industry, Health and Social Services

https://www.congress.gov/bill/115th-congress/house-bill/5228/all-info